论文部分内容阅读
目的观察血必净佐治重症胸腹损伤患者的临床效果。方法将150例重症胸腹损伤患者随机分为观察组和对照组各75例。对照组采用常规对症治疗。观察组在对照组基础上加用血必净注射液治疗。对比2组治疗后第1、3、5、7天的APACHEⅡ评分和住院时间、下床时间。结果治疗后第1天,2组APACHEⅡ评分比较差异无统计学意义(P>0.05)。治疗后第3、5、7天2组APACHEⅡ评分均逐渐降低,且观察组低于对照组,差异均有统计学意义(P<0.05)。观察组住院时间、下床时间短于对照组,差异均有统计学意义(P<0.05)。结论血必净辅治重症胸腹损伤患者,可明显提高患者疗效,缩短住院时间和下床活动时间,值得临床推广应用。
Objective To observe the clinical effect of Xuebijing in treating patients with severe thoracoabdominal injury. Methods 150 patients with severe thoracoabdominal injury were randomly divided into observation group and control group of 75 cases. Control group using conventional symptomatic treatment. The observation group was added Xuebijing injection on the basis of the control group. The APACHEⅡscore and hospital stay, bed-out time on the 1st, 3rd, 5th and 7th days after treatment were compared between the two groups. Results On the first day after treatment, there was no significant difference in APACHEⅡscore between the two groups (P> 0.05). On the 3rd, 5th and 7th day after treatment, the APACHEⅡscores in both groups were gradually decreased, and the observation group was lower than the control group, the difference was statistically significant (P <0.05). The length of hospital stay and the time to bed in the observation group were shorter than those in the control group, with significant differences (P <0.05). Conclusion Xuebijing treatment of patients with severe chest and abdomen injury, can significantly improve the efficacy of patients, shorter hospital stay and ambulation time, worthy of clinical application.